<DOC>
	<DOCNO>NCT02629393</DOCNO>
	<brief_summary>To evaluate safety efficacy ALXN1101 neonate patient MoCD Type A</brief_summary>
	<brief_title>Study ALXN1101 Neonates With Molybdenum Cofactor Deficiency ( MOCD ) Type A</brief_title>
	<detailed_description />
	<mesh_term>Metal Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Molybdenum</mesh_term>
	<criteria>Male female neonatal patient ( 1 28 day age [ inclusive ] time ALXN1101 administration , day 1 age corresponding day birth ) Diagnosis MoCD Type A , base Prenatal genetic diagnosis , Onset clinical and/or laboratory sign symptoms consistent MoCD Type A ( eg , seizure , exaggerate startle response , highpitched cry , axial hypotonia , limb hypertonia , feed difficulty , elevate urinary sulfite and/or SSC , elevate xanthine urine blood , low absent uric acid urine blood ) within first 28 day birth Parent legal guardian must sign informed consent form ( ICF ) prior study procedure perform Diagnosis MoCD Type A ( may determine initiation study drug ) Condition consider treat physician contraindication therapy , include evidence abnormality brain image attributable MoCD Type A , might otherwise interfere patient 's participation study , pose additional risk patient , confound patient assessment Antenatal and/or postnatal brain image prior initiation treatment ALXN1101 indicate cortical subcortical cystic encephalomalacia , clinically significant intracranial hemorrhage , abnormality brain imaging determine treat physician clinically significant Modified Glasgow Coma Scale ( mGCS ) Infants Children score less 7 24 hour ( This criterion apply child less 1 day age ) .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Molybdenum Cofactor Deficiency ( MoCD )</keyword>
	<keyword>Molybdenum Cofactor ( MoCo ) biosynthesis</keyword>
	<keyword>sulfite oxidase ( SO )</keyword>
	<keyword>S sulfocysteine ( SSC )</keyword>
	<keyword>xanthine oxidoreductase</keyword>
	<keyword>aldehyde oxidase</keyword>
</DOC>